title: The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population.
abstract: BACKGROUND
  Type 2 diabetes mellitus, obesity and hepatic steatosis showed a strong correlation with metabolic syndrome. However, data on the influence of pancreatic steatosis on metabolic syndrome are lacking.
  
  
  OBJECTIVE
  Our aim is to perform the prevalence of pancreatic steatosis in adults and its association with metabolic syndrome in a Chinese population.
  
  
  METHODS
  This was a cross-sectional study, randomly selected. A total of 1190 health examination subjects were recruited. Pancreatic steatosis or hepatic steatosis was diagnosed via trans-abdominal sonography. The clinical and metabolic parameters were compared between the two groups, and their associations with pancreatic steatosis were examined.
  
  
  RESULTS
  The prevalence of pancreatic steatosis was 30.7%. The presence of pancreatic steatosis was significantly increased by age, gender, central obesity, hepatic steatosis, hypertriglyceridemia and hyperglycemia. In the logistic regression analysis, age (P < 0.05), central obesity (P < 0.01), diabetes (P < 0.05), hypertriglyceridemia (P < 0.05) and hepatic steatosis (P < 0.01) were independently associated with pancreatic steatosis. The number of the parameters of the metabolic syndrome in pancreatic steatosis group was more than that in non-pancreatic steatosis group [(2.5 ± 1.1) vs (1.4 ± 1.2)] (P < 0.01).
  
  
  CONCLUSIONS
  The pancreatic steatosis is strongly associated with the parameters of metabolic syndrome, such as central obesity, diabetes, and hepatic steatosis.
authors.affiliation: Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
authors.forename: Jie
authors.initials: J
authors.lastname: Zhou
authors.affiliation: Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China. Electronic address: liminglong@medmail.com.cn.
authors.forename: Ming-Long
authors.initials: ML
authors.lastname: Li
authors.affiliation: Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
authors.forename: Dan-Dan
authors.initials: DD
authors.lastname: Zhang
authors.affiliation: Physical Examination Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
authors.forename: Hai-Yan
authors.initials: HY
authors.lastname: Lin
authors.affiliation: Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
authors.forename: Xiao-Hua
authors.initials: XH
authors.lastname: Dai
authors.affiliation: Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
authors.forename: Xiang-Lan
authors.initials: XL
authors.lastname: Sun
authors.affiliation: Department of Endocrinology, Jinan Central Hospital Affiliated to Shandong University, Jinan, China.
authors.forename: Jian-Ting
authors.initials: JT
authors.lastname: Li
authors.affiliation: Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
authors.forename: Li-Yuan
authors.initials: LY
authors.lastname: Song
authors.affiliation: Physical Examination Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
authors.forename: Hui
authors.initials: H
authors.lastname: Peng
authors.affiliation: Physical Examination Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
authors.forename: Meng-Meng
authors.initials: MM
authors.lastname: Wen
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D044466:Asian People / Q000706:statistics & numerical data; D015992:Body Mass Index; D002681:China / Q000453:epidemiology; D003430:Cross-Sectional Studies; D005234:Fatty Liver / Q000150:complications; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000453:epidemiology; D015228:Hypertriglyceridemia / Q000150:complications / Q000453:epidemiology; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications* / Q000000981:diagnostic imaging / Q000453:epidemiology*; D008875:Middle Aged; D056128:Obesity, Abdominal / Q000150:complications / Q000453:epidemiology; D010179:Pancreas / Q000000981:diagnostic imaging; D010182:Pancreatic Diseases / Q000150:complications* / Q000000981:diagnostic imaging / Q000453:epidemiology*; D015995:Prevalence; D012307:Risk Factors; D012737:Sex Factors; D014463:Ultrasonography
keywords: Diabetes mellitus; Hepatic steatosis; Metabolic syndrome; Obesity; Pancreatic steatosis; Trans-abdominal sonography